Work

Comparison of Early Plasma Exposure to DHE for Marketed and Development Stage Nasal, Inhalation, and Injectable Products (2625)

Year: 2020

Type: article

Source: Neurology

DOI: 10.1212/wnl.94.15_supplement.2625

Authors: Kelsey Satterly, Stephen Shrewsbury, John Hoekman

Institution: Impel Neuropharma (United States)

Language: English

Topic: Advanced Drug Delivery Systems

Subfield: Pharmaceutical Science

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389450501

FWCI:

Cites:

Cited by:

Related to: 10